Haptoglobin as an early serum biomarker of virus-induced autoimmune type 1 diabetes in biobreeding diabetes resistant and LEW1.WR1 rats
Authors:
Open Access
- 1 November 2010
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 235 (11) , 1328-1337
Abstract
Proteomic profiling of serum is a powerful technique to identify differentially expressed proteins that can serve as biomarkers predictive of disease onset. In this study, we utilized two-dimensional (2D) gel analysis followed by matrix-assisted-laser desorption/ionization time-of-flight mass spectrometry analysis to identify putative serum biomarkers for autoimmune type 1 diabetes (T1D) in biobreeding diabetes resistant (BBDR) rats induced to express the disease. Treatment with toll-like receptor 3 ligand, polyinosinic:polycytidilic acid (pIC), plus infection with Kilham rat virus (KRV), a rat parvovirus, results in nearly 100% of young BBDR rats becoming diabetic within 11–21 d. Sera collected from prediabetic rats at early time points following treatment with pIC + KRV were analyzed by 2D gel electrophoresis and compared with sera from control rats treated with phosphate-buffered saline, pIC alone or pIC + H1, a non-diabetogenic parvovirus. None of the latter three control treatments precipitates T1D. 2D gel analysis revealed that haptoglobin, an acute phase and hemoglobin scavenger protein, was differentially expressed in the sera of rats treated with pIC + KRV relative to control groups. These results were confirmed by Western blot and enzyme-linked immunosorbent assay studies, which further validated haptoglobin levels as being differentially increased in the sera of pIC + KRV-treated rats relative to controls during the first week following infection. Early elevations in serum haptoglobin were also observed in LEW1.WR1 rats that became diabetic following infection with rat cytomegalovirus. The identification and validation of haptoglobin as a putative serum biomarker for autoimmune T1D in rats now affords us the opportunity to test the validity of this protein as a biomarker for human T1D, particularly in those situations where viral infection is believed to precede the onset of disease.Keywords
This publication has 35 references indexed in Scilit:
- Virus-Plus-Susceptibility Gene Interaction Determines Crohn's Disease Gene Atg16L1 Phenotypes in IntestineCell, 2010
- Infection With Viruses From Several Families Triggers Autoimmune Diabetes in LEW.1WR1 RatsDiabetes, 2009
- Virus-Induced Autoimmune Diabetes in the LEW.1WR1 Rat Requires Iddm14 and a Genetic Locus Proximal to the Major Histocompatibility ComplexDiabetes, 2009
- Thymus‐specific deletion of insulin induces autoimmune diabetesThe EMBO Journal, 2009
- Can We Learn From Viruses How to Prevent Type 1 Diabetes?Diabetes, 2009
- CD3-specific antibodies: a portal to the treatment of autoimmunityNature Reviews Immunology, 2007
- Susceptibility to type I diabetes: HLA-DQ and DR revisitedImmunology Today, 1996
- Beta-Cell Autoantibodies in Infants and Toddlers without IDDM Relatives: Diabetes Autoimmunity Study in the Young (DAISY)Journal of Autoimmunity, 1996
- Prevention of Autoimmune Diabetes in the BB Rat by Intrathymic Islet Transplantation at BirthScience, 1992
- Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytesFEBS Letters, 1989